Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03753659
Brief Title: IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)

First Submitted : November 19, 2018
First Submitted that Met QC Criteria : November 22, 2018
First Posted : November 27, 2018

Last Update Submitted that Met QC Criteria : August 25, 2021
Last Update Posted : August 26, 2021